Patent · US Active

Virus purification

US11207397B2 · kind B2 · utility

5Cited by

8References

12Claims

0Family size

Assignee

Valneva SE · FR

Inventors

Jana Barbero Calzado · Wien, AT
Mario Nebenführ · Wien, AT
Robert Schiegl · Siegenfeld, AT
Michael Weber · Wien, AT
Jürgen Heindl-Wruss · Wien, AT

Key dates

Filing date	Dec 4, 2019
Grant date	Dec 28, 2021
Priority date	—
Expiry date	Dec 4, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.